deltatrials
Terminated NA NCT00509197

Should Non-eosinophilic Asthmatic Subjects be Treated With Inhaled Corticosteroids?

Sponsor: Laval University

Conditions Asthma
Interventions Fluticasone Placebo (sham inhaler)
Updated 9 times since 2017 Last updated: Jul 5, 2016 Started: Oct 31, 2007 Primary completion: May 31, 2010 Completion: Sep 30, 2010

A NA clinical study on Asthma, this trial is terminated or withdrawn. The trial is conducted by Laval University and has accumulated 9 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Change History

9 versions recorded

  1. Sep 2025 — Present [monthly]

    Terminated NA

  2. Sep 2024 — Sep 2025 [monthly]

    Terminated NA

  3. Jul 2024 — Sep 2024 [monthly]

    Terminated NA

  4. Jan 2023 — Jul 2024 [monthly]

    Terminated NA

  5. Dec 2022 — Jan 2023 [monthly]

    Terminated NA

▶ Show 4 earlier versions

  1. Dec 2021 — Dec 2022 [monthly]

    Terminated NA

  2. Jan 2021 — Dec 2021 [monthly]

    Terminated NA

  3. Jun 2018 — Jan 2021 [monthly]

    Terminated NA

  4. Jan 2017 — Jun 2018 [monthly]

    Terminated NA

    First recorded

Oct 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Laval University
  • McGill University
  • University of British Columbia
  • University of Calgary
  • University of Ottawa
  • Université de Montréal
Data source: Université de Montréal

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Calgary, Canada
  • • Hamilton, Canada
  • • Montreal, Canada
  • • Ottawa, Canada
  • • Québec, Canada
  • • Vancouver, Canada